相关实验视频
Updated: Jun 25, 2025

06:24
Establishing 3D Endometrial Organoids from the Mouse Uterus
Published on: January 6, 2023
6.1K
卡伯戈林向多个途径来抑制PRL分泌,并增加 stromal纤维化
Dongyun Zhang1, Willy Hugo1, Marvin Bergsneider2
1Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
European journal of endocrinology
|May 23, 2024
概括
多巴胺激动剂疗法,像卡伯戈林 (CBG),影响益生菌瘤瘤及其微观环境. CBG治疗激活CD8+T细胞,可能导致瘤细胞死亡.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 甲状腺瘤是脑下垂体瘤,通常用多巴胺激动剂治疗.
- 多巴胺激动剂作用的精确机制,包括对瘤微环境的影响,需要进一步阐明.
研究的目的:
- 研究在人类前乳腺瘤瘤中多巴胺激动剂治疗的目标和非目标机制.
- 分析卡贝戈林 (CBG) 对瘤和非瘤细胞在益生菌瘤微环境中的影响.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 用于手术切除的前乳腺瘤.
- 样本包括卡伯戈林治疗和未经治疗的患者的瘤.
- 细胞组成和转录景观在各组之间进行了比较.
主要成果:
- 鉴定了六种主要细胞群:瘤细胞,免疫细胞,肌层细胞,前代细胞,增殖细胞和红细胞.
- 卡伯戈林治疗的瘤细胞显示,与激素分泌相关的基因的表达减少.
- 在卡伯戈林治疗的组织中观察到,激活的CD8+ T细胞表达细胞毒性分子和炎症性细胞因子的数量增加.
结论:
- 单细胞RNA测序揭示了卡伯戈林治疗和未治疗的前性腺瘤中明显的转录组特征.
- 这项研究首次确定了卡伯戈林治疗后CD8+T细胞的激活.
- 已激活的CD8+ T细胞可能有助于卡贝戈林在益生菌瘤中的瘤杀伤作用.
关键词:
卡伯戈林尼 (Cabergoline) 是一种可怕的药物.pituitary 瘤 pituitary 瘤 瘤 瘤 瘤 瘤 瘤孕产妇的乳腺癌 (prolactinomas) 是一个这就是scRNA-seqq.瘤微环境是一个微环境.更多相关视频
相关概念视频
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
309
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
309
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
731
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
731
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
Parkinson's Disease: Treatment
261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261

